Andreia Albuquerque Cunha Lopes Morais, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cortical Spreading Depression | 16 | 2023 | 288 | 5.240 |
Why?
|
Infarction, Middle Cerebral Artery | 4 | 2024 | 485 | 1.540 |
Why?
|
Vagus Nerve Stimulation | 4 | 2022 | 228 | 1.250 |
Why?
|
Hyperalgesia | 2 | 2023 | 532 | 1.170 |
Why?
|
Migraine Disorders | 5 | 2023 | 1703 | 1.030 |
Why?
|
Leukoaraiosis | 1 | 2022 | 116 | 0.740 |
Why?
|
Seizures | 2 | 2024 | 2957 | 0.680 |
Why?
|
Migraine with Aura | 1 | 2020 | 204 | 0.610 |
Why?
|
Subarachnoid Hemorrhage | 1 | 2023 | 1033 | 0.510 |
Why?
|
Aneurysm, Ruptured | 1 | 2020 | 464 | 0.490 |
Why?
|
Depression | 4 | 2023 | 8126 | 0.480 |
Why?
|
Mice, Inbred C57BL | 5 | 2024 | 22174 | 0.460 |
Why?
|
Carthamus tinctorius | 2 | 2017 | 2 | 0.440 |
Why?
|
Safflower Oil | 2 | 2017 | 29 | 0.440 |
Why?
|
Lactation | 3 | 2017 | 397 | 0.440 |
Why?
|
Behavior, Animal | 2 | 2020 | 1878 | 0.430 |
Why?
|
Cerebral Hemorrhage | 2 | 2023 | 2656 | 0.420 |
Why?
|
Hippocampus | 1 | 2024 | 3766 | 0.380 |
Why?
|
Intracranial Aneurysm | 1 | 2020 | 1285 | 0.360 |
Why?
|
Animals | 28 | 2024 | 168475 | 0.350 |
Why?
|
Mice | 13 | 2024 | 81539 | 0.330 |
Why?
|
Cerebral Cortex | 4 | 2019 | 5779 | 0.320 |
Why?
|
Rats, Sprague-Dawley | 4 | 2023 | 8181 | 0.320 |
Why?
|
Rats | 10 | 2023 | 23741 | 0.290 |
Why?
|
Rats, Wistar | 8 | 2019 | 1848 | 0.280 |
Why?
|
Disease Models, Animal | 6 | 2024 | 18255 | 0.270 |
Why?
|
Anxiety | 2 | 2020 | 4573 | 0.270 |
Why?
|
Estrus | 1 | 2023 | 70 | 0.220 |
Why?
|
Mefenamic Acid | 1 | 2022 | 5 | 0.200 |
Why?
|
Antioxidants | 2 | 2014 | 1668 | 0.200 |
Why?
|
Brain Infarction | 1 | 2024 | 290 | 0.200 |
Why?
|
Bicuculline | 1 | 2021 | 96 | 0.190 |
Why?
|
Desoxycorticosterone | 1 | 2020 | 46 | 0.180 |
Why?
|
4-Aminopyridine | 1 | 2021 | 80 | 0.180 |
Why?
|
Kainic Acid | 1 | 2021 | 203 | 0.180 |
Why?
|
Stroke | 4 | 2024 | 9758 | 0.180 |
Why?
|
Potassium Channel Blockers | 1 | 2021 | 161 | 0.180 |
Why?
|
rho-Associated Kinases | 1 | 2022 | 281 | 0.180 |
Why?
|
Pancreatic Elastase | 1 | 2020 | 127 | 0.180 |
Why?
|
Tetrodotoxin | 1 | 2021 | 246 | 0.170 |
Why?
|
Mice, Inbred ICR | 1 | 2020 | 364 | 0.170 |
Why?
|
Male | 18 | 2024 | 360846 | 0.170 |
Why?
|
Gene Knock-In Techniques | 1 | 2021 | 421 | 0.170 |
Why?
|
Guanosine | 1 | 2019 | 48 | 0.160 |
Why?
|
Inflammation | 1 | 2019 | 10774 | 0.160 |
Why?
|
Pain Threshold | 1 | 2023 | 604 | 0.160 |
Why?
|
Endothelin-1 | 1 | 2020 | 302 | 0.160 |
Why?
|
Progesterone | 1 | 2023 | 742 | 0.160 |
Why?
|
Hematoma | 1 | 2023 | 767 | 0.160 |
Why?
|
Laser-Doppler Flowmetry | 1 | 2018 | 239 | 0.150 |
Why?
|
Penicillins | 1 | 2021 | 402 | 0.150 |
Why?
|
Nervous System | 1 | 2021 | 545 | 0.150 |
Why?
|
Vagus Nerve | 1 | 2020 | 458 | 0.140 |
Why?
|
Mice, Transgenic | 2 | 2020 | 9542 | 0.140 |
Why?
|
Corpus Callosum | 1 | 2022 | 751 | 0.140 |
Why?
|
Ischemic Attack, Transient | 1 | 2023 | 882 | 0.140 |
Why?
|
Dexamethasone | 1 | 2014 | 1948 | 0.140 |
Why?
|
Overnutrition | 1 | 2016 | 25 | 0.140 |
Why?
|
Vitamins | 1 | 2014 | 1635 | 0.130 |
Why?
|
Estradiol | 1 | 2023 | 1937 | 0.130 |
Why?
|
Headache | 2 | 2022 | 1256 | 0.130 |
Why?
|
Brain Stem | 1 | 2021 | 858 | 0.130 |
Why?
|
Brain | 6 | 2022 | 27121 | 0.130 |
Why?
|
Fatty Acids, Omega-6 | 1 | 2016 | 225 | 0.120 |
Why?
|
Oxidants | 1 | 2014 | 169 | 0.110 |
Why?
|
Litter Size | 1 | 2013 | 49 | 0.110 |
Why?
|
Light | 1 | 2018 | 1353 | 0.100 |
Why?
|
Female | 11 | 2024 | 392705 | 0.100 |
Why?
|
Motor Activity | 1 | 2012 | 2715 | 0.100 |
Why?
|
Dentate Gyrus | 1 | 2013 | 164 | 0.100 |
Why?
|
Cell Shape | 1 | 2013 | 371 | 0.100 |
Why?
|
Recovery of Function | 1 | 2022 | 2979 | 0.100 |
Why?
|
Oxidative Stress | 2 | 2017 | 3113 | 0.100 |
Why?
|
Lipid Peroxidation | 2 | 2017 | 271 | 0.090 |
Why?
|
Maze Learning | 1 | 2013 | 483 | 0.090 |
Why?
|
Ascorbic Acid | 1 | 2014 | 655 | 0.090 |
Why?
|
Electric Stimulation | 1 | 2016 | 1736 | 0.090 |
Why?
|
Calcium | 1 | 2013 | 5722 | 0.090 |
Why?
|
Endovascular Procedures | 1 | 2024 | 2183 | 0.090 |
Why?
|
Models, Animal | 1 | 2016 | 2112 | 0.080 |
Why?
|
Brain Ischemia | 1 | 2022 | 3049 | 0.080 |
Why?
|
Malnutrition | 1 | 2014 | 645 | 0.070 |
Why?
|
Catalase | 1 | 2017 | 218 | 0.070 |
Why?
|
Sex Factors | 1 | 2020 | 10554 | 0.070 |
Why?
|
Survival Rate | 1 | 2020 | 12723 | 0.070 |
Why?
|
Memory Disorders | 1 | 2013 | 1199 | 0.060 |
Why?
|
Phenotype | 1 | 2023 | 16592 | 0.060 |
Why?
|
Glutathione | 1 | 2017 | 583 | 0.060 |
Why?
|
Superoxide Dismutase | 1 | 2017 | 594 | 0.060 |
Why?
|
Microglia | 1 | 2013 | 1362 | 0.060 |
Why?
|
Calcimycin | 1 | 2013 | 213 | 0.060 |
Why?
|
Body Weight | 3 | 2019 | 4618 | 0.060 |
Why?
|
Myocardium | 1 | 2016 | 4725 | 0.060 |
Why?
|
Aging | 1 | 2012 | 8710 | 0.050 |
Why?
|
Rodentia | 1 | 2023 | 262 | 0.050 |
Why?
|
Sulfotransferases | 1 | 2022 | 150 | 0.050 |
Why?
|
Oxidation-Reduction | 1 | 2017 | 2231 | 0.050 |
Why?
|
Random Allocation | 2 | 2016 | 2395 | 0.050 |
Why?
|
Liver | 1 | 2016 | 7528 | 0.050 |
Why?
|
Laboratories | 1 | 2023 | 458 | 0.040 |
Why?
|
Prospective Studies | 1 | 2024 | 54423 | 0.040 |
Why?
|
Animals, Newborn | 1 | 2014 | 2677 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2023 | 1702 | 0.040 |
Why?
|
Electrophysiological Phenomena | 1 | 2019 | 307 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 1 | 2024 | 36426 | 0.030 |
Why?
|
Weaning | 1 | 2016 | 103 | 0.030 |
Why?
|
Plant Preparations | 1 | 2016 | 94 | 0.030 |
Why?
|
Glucocorticoids | 1 | 2014 | 2161 | 0.030 |
Why?
|
Malondialdehyde | 1 | 2014 | 112 | 0.030 |
Why?
|
Maternal Nutritional Physiological Phenomena | 1 | 2016 | 389 | 0.030 |
Why?
|
Humans | 6 | 2023 | 761596 | 0.030 |
Why?
|
Cerebrovascular Circulation | 1 | 2023 | 2727 | 0.030 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2022 | 2273 | 0.020 |
Why?
|
Hyperlipidemias | 1 | 2016 | 771 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2022 | 5247 | 0.020 |
Why?
|
Pregnancy | 2 | 2017 | 29890 | 0.020 |
Why?
|
Cell Count | 1 | 2013 | 1835 | 0.020 |
Why?
|
Hyperglycemia | 1 | 2016 | 1376 | 0.020 |
Why?
|
Research Design | 1 | 2023 | 6180 | 0.020 |
Why?
|
Weight Gain | 1 | 2016 | 2348 | 0.020 |
Why?
|
Electroencephalography | 1 | 2012 | 6237 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2023 | 20100 | 0.020 |
Why?
|
Dietary Supplements | 1 | 2016 | 3415 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2014 | 10766 | 0.010 |
Why?
|
Age Factors | 1 | 2013 | 18399 | 0.010 |
Why?
|
Obesity | 1 | 2016 | 12947 | 0.010 |
Why?
|
Aged | 1 | 2022 | 169310 | 0.010 |
Why?
|